锘� EU drug regulator begins real-time review of Sinovac's COVID-19 vaccine | Inquirer 黑料社

.simplePullQuote{--wpr-bg-74a9011e-b7fa-48ad-a4f3-f0c98e110fac: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-77d404d8-342a-435e-93f0-220d3247341d: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-7117213e-5f14-4929-96bd-71760b038cbb: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-b8b341c1-600b-4896-9f2a-01144cfc8750: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-a4735f42-0dd4-49f4-a891-87cf21054890: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-58676ae8-ef08-4f84-88cc-865dfbbd84a3: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-89ea2b44-b433-4a4a-944c-61adf747700a: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-a281294c-eb3f-4c43-ab7a-a9864a0067d4: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-9ef11590-ba89-496d-9b5e-da665de5d1eb: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-a652dd9d-463f-4f6c-9f3d-aa14c4c9d37d: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-a72b5b26-f433-4b4b-b162-4e06de907ae5: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-05af78ea-49ff-4e18-8c41-00f55af73422: url('/single2017/images/quote-texture.png');}.simplePullQuote{--wpr-bg-d76fe535-d8ec-4222-9b64-499a674b4660: url('/single2017/images/quote-2021.png');}.simplePullQuote{--wpr-bg-f9fa999d-fdd1-46ed-8833-b7f5c900d972: url('/single2017/images/quote-texture.png');}.sib-flag{--wpr-bg-77985b76-9c53-4ed2-ba92-ac53957fb4b9: url('https://static.brevo.com/images/flags.png');}.simplePullQuote{--wpr-bg-731f7466-8e58-4038-a2c6-9357185a330e: url('/wp-content/plugins/simple-pull-quote/images/quote.png');}.rll-youtube-player .play{--wpr-bg-14aaa841-3acc-458d-bd70-851a69c86027: url('/wp-content/plugins/wp-rocket/assets/img/youtube.png');}#inq-banner-2021-FT-survey{--wpr-bg-6e290756-578f-4f00-ae7c-8718b2e04e90: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_980x80-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-ed68db51-9ab2-47a1-b7e0-70c84c9237a1: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_980x80-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-4030b16d-a7e8-4ccd-827e-9c7820ee4f7f: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_980x80-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-a66abe4b-2bce-4098-ab18-a0e9f8865fa6: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_375x100-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-6d766bfc-4ebe-4d6f-b133-aa1a367a05ee: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_375x100-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-67fd0833-93a7-4061-a852-ed1696126e8a: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_375x100-extended-ribbon.gif');}#inq-banner-2021-FT-survey{--wpr-bg-8b522b82-c3d9-417b-ad55-a50598d591f0: url('https://www.inquirer.net/wp-content/uploads/2024/12/IQOS_375x100-extended-ribbon.gif');}#inqplus-cta-wrap{--wpr-bg-17acff68-b4db-4079-abd3-6acd4296b97e: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}#newsletter-cta-wrap{--wpr-bg-2a7d132a-b3b6-4f52-bc69-fd38e0c1611f: url('/single2017/images/inqplus-sub/inqplus-cta-bg1.png');}

黑料社

FOLLOW US:

Subscribe to our daily newsletter

Your subscription could not be saved. Please try again.

Your subscription has been successful.

By providing an email address. I agree to the and acknowledge that I have read the .

EU drug regulator begins real-time review of Sinovac’s COVID-19 vaccine

Reuters / 05:22 PM May 04, 2021

EU drug regulator begins real-time review of Sinovac's COVID-19 vaccine

FILE PHOTO: A healthcare worker prepares a syringe with a dose of Sinovac’s COVID-19 vaccine at the Bang Khun Thian Geriatric Hospital in Bangkok, Thailand April 21, 2021. REUTERS/Athit Perawongmetha

Europe’s medicines regulator said on Tuesday it has started a real-time review of Sinovac’s COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.

Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential approvals, the European Medicines Agency said.

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

READ NEXT

Woman who allegedly threatens sex trafficking victims with wit...

Metro Manila cities roll out Russian-made Sputnik V jab

EDITORS' PICK

MOST READ

NBI recommends raps against ex-Albay gov over quarry receipts聽

SC justice questions Congress鈥� right to decide PhilHealth budget

globalnation

globalnation

business

usa

www

globalnation

TAGS: COVID-19, Sinovac, vaccine

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Disclaimer: Comments do not represent the views of 黑料社. We reserve the right to exclude comments which are inconsistent with our editorial standards. FULL DISCLAIMER

© Copyright 1997-2025 黑料社 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.